- Home
- NVG vs BHC Comparison
NVG vs BHC Comparison
Compare NVG & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVG
- BHC
- Stock Information
- Founded
- NVG 1999
- BHC N/A
- Country
- NVG United States
- BHC Canada
- Employees
- NVG N/A
- BHC N/A
- Industry
- NVG Investment Managers
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- NVG Finance
- BHC Health Care
- Exchange
- NVG Nasdaq
- BHC Nasdaq
- Market Cap
- NVG 2.7B
- BHC 2.6B
- IPO Year
- NVG N/A
- BHC N/A
- Fundamental
- Price
- NVG $12.26
- BHC $6.47
- Analyst Decision
- NVG
- BHC Hold
- Analyst Count
- NVG 0
- BHC 5
- Target Price
- NVG N/A
- BHC $7.20
- AVG Volume (30 Days)
- NVG 568.8K
- BHC 1.4M
- Earning Date
- NVG 01-01-0001
- BHC 04-30-2025
- Dividend Yield
- NVG 4.65%
- BHC N/A
- EPS Growth
- NVG N/A
- BHC N/A
- EPS
- NVG N/A
- BHC N/A
- Revenue
- NVG N/A
- BHC $9,625,000,000.00
- Revenue This Year
- NVG N/A
- BHC $4.76
- Revenue Next Year
- NVG N/A
- BHC $2.05
- P/E Ratio
- NVG N/A
- BHC N/A
- Revenue Growth
- NVG N/A
- BHC 9.91
- 52 Week Low
- NVG $9.68
- BHC $3.96
- 52 Week High
- NVG $12.21
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- NVG 37.09
- BHC 35.56
- Support Level
- NVG $12.13
- BHC $6.91
- Resistance Level
- NVG $12.52
- BHC $7.45
- Average True Range (ATR)
- NVG 0.11
- BHC 0.27
- MACD
- NVG -0.03
- BHC -0.05
- Stochastic Oscillator
- NVG 22.03
- BHC 2.00
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.